Healthcare Stocks

Business

Benchmark Names T-Mobile (TMUS) a 2026 Best Idea

T-Mobile US Inc. (NASDAQ:TMUS) ranks among the most promising QQQ stocks according to hedge funds. On January 21, Benchmark reaffirmed its Buy rating on T-Mobile US Inc. (NASDAQ:TMUS) with a $295 price target, classifying the telecom provider as a “2026 Benchmark Best Idea.” The firm remains confident that T-Mobile’s network strengths and potential for expanded […]

Jan 30, 2026

Business

Three TSX Venture Minnows Drawing Investor Scrutiny Amid Steady Rate Environment

As the Bank of Canada holds rates steady, speculative capital is sifting through junior resource stocks. We examine three micro-caps—a driller, an explorer, and an oil hopeful—navigating unique challenges and opportunities in early 2026.

Jan 30, 2026

Business

Insider Bets on Small Caps: Where Executives Are Putting Their Money in a Quiet January 2026

With major indices treading water after the Fed's steady rates, savvy investors are turning to overlooked small-cap stocks where insider buying signals conviction. We examine three companies where executives are backing their firms with their own capital.

Jan 30, 2026

Business

SuperX AI Soars 48% in a Week, Delivering Windfall for Major Private Backers

A dramatic surge in SuperX AI Technology's share price has spotlighted its concentrated ownership structure, with private companies holding a dominant 34% stake and reaping the largest rewards from the recent rally. As the AI-driven healthcare sector heats up, investor attention turns to who holds the reins at this promising but closely held firm.

Jan 30, 2026

Business

Bizarre Jailbreak Plot Foiled: Minnesota Man Posed as FBI Agent to Free Accused CEO Killer

A Minnesota pizza worker's audacious and poorly executed scheme to impersonate a federal officer and secure the release of Luigi Mangione, the man accused of assassinating a healthcare CEO, has resulted in his own arrest at a Brooklyn detention center.

Jan 30, 2026

Business

Beyond the Headlines: Unearthing Investment Opportunities in Middle Eastern Markets Amidst Geopolitical Uncertainty

While regional tensions and market volatility capture headlines, a closer look reveals resilient companies with strong fundamentals. Driven by robust earnings and strategic positioning, select stocks in sectors from renewable energy to infrastructure present compelling cases for value-oriented investors navigating the complex landscape of early 2026.

Jan 30, 2026

Business

Crypto Rout Ripples Through Corporate Treasuries: MicroStrategy and BitMine Shares Tumble

A sharp downturn in cryptocurrency markets has spilled over into the stocks of major corporate holders, with MicroStrategy and BitMine leading losses as their aggressive accumulation strategies face mounting pressure.

Jan 30, 2026

Business

Beyond the Headlines: Three European Small-Caps With Market Caps Over €10M in Focus

As the STOXX Europe 600 grapples with volatility, some investors are turning their gaze to smaller, often overlooked companies. We examine three European penny stocks, each with a market capitalization exceeding €10 million, assessing their potential amidst a challenging macroeconomic backdrop.

Jan 30, 2026

Business

Nordex Shares Soar 197% in One Year, Outpacing Broader Market as Wind Energy Sector Gains Momentum

Investors who backed wind turbine manufacturer Nordex SE (ETR:NDX1) twelve months ago have seen their holdings nearly triple in value, with shares skyrocketing 197%. The surge highlights a powerful rally in renewable energy stocks amid favorable policy shifts and strong order books.

Jan 30, 2026

Business

ResMed Posts Strong Q2 Growth on New Product Momentum and GLP-1 Therapy Tailwinds

ResMed Inc. reports an 11% revenue surge for its second fiscal quarter, driven by robust mask sales and strategic acquisitions, while navigating competitive pressures and capitalizing on emerging healthcare trends.

Jan 30, 2026

Business

OSI Systems Beats Expectations, Raises Outlook Despite Sector Headwinds

OSI Systems posts record Q2 revenue and lifts full-year EPS guidance, navigating softness in security bookings and healthcare challenges with optimism for a stronger second half.

Jan 30, 2026

Business

technotrans (ETR:TTR1) Shows Steady Growth, Balanced Leadership Amid Market's 'Story Stock' Frenzy

While flashy, unprofitable tech stocks often dominate headlines, German thermal management specialist technotrans demonstrates that disciplined earnings growth and reasonable executive compensation can build a more sustainable investment case, as its EPS and margins climb.

Jan 30, 2026

Business

Beyond the Headlines: Three Middle Eastern Equities Defying Geopolitical Gloom

While regional tensions weigh on Gulf bourses, a closer look reveals resilient companies with strong fundamentals poised for growth. We analyze three under-the-radar stocks from Turkey, Saudi Arabia, and Israel that are navigating the volatility.

Jan 30, 2026

Business

Cardinal Health Shares Surge on Strong Earnings, But Valuation Questions Loom

Cardinal Health (CAH) stock has drawn renewed investor interest following robust financial results, with revenue topping $234 billion and net income near $1.6 billion. The healthcare distributor's shares have rallied over 66% in the past year, though its premium valuation compared to peers is sparking debate among analysts.

Jan 30, 2026

Business

Axis REIT: A Steady Performer in a Volatile Market

While speculative 'story stocks' capture headlines, Axis Real Estate Investment Trust (KLSE:AXREIT) presents a compelling case for investors seeking stability through consistent earnings growth and strong insider alignment.

Jan 30, 2026

Business

Asia Markets Rebound Sharply on Tech Rally, Eyes on Earnings and Trade Tensions

Asian equities staged a strong recovery on Tuesday, with South Korea's Kospi and Japan's Nikkei leading gains as investors returned to tech stocks. The rebound follows recent volatility, with markets now focused on corporate earnings and geopolitical risks.

Feb 3, 2026

Business

Coles Group's Steady Returns Fail to Ignite Growth Engine, Analysts Look Elsewhere for Multi-Bagger Potential

Despite a respectable return on capital, Coles Group's flat performance over five years signals a mature business in a holding pattern, leading investors to question its long-term compounding potential.

Feb 3, 2026

Business

AbbVie's Q4 Earnings in Focus: Can the Pharma Giant Sustain Its Growth Momentum?

All eyes are on AbbVie as it prepares to release its fourth-quarter earnings. With a history of topping revenue forecasts, the market watches to see if its strategic shifts can continue to deliver amid evolving industry pressures.

Feb 3, 2026

Business

PTC Earnings Preview: Can the Software Giant Sustain Its Momentum Amid Market Volatility?

As PTC prepares to release its Q4 financial results, investors are weighing its strong historical performance against a turbulent market for vertical software stocks. Here’s the breakdown.

Feb 3, 2026

Business

Markel Group Earnings Preview: Can the Specialty Insurer Maintain Momentum?

Markel Group is set to report its latest quarterly earnings after the bell Wednesday. Investors will be watching to see if the insurer can build on last quarter's strong performance amid a challenging market for property and casualty stocks.

Feb 3, 2026